💊 दवाएँ A-Z 🧬 लक्ष्य 🛠 उपकरण 📚 मार्गदर्शिकाएँ
सभी दवाएँ दवा वर्ग चिकित्सीय क्षेत्र दुष्प्रभाव
मार्गदर्शिकाएँ शब्दकोश समयरेखा
तुलनाएँ दवाओं की यात्राएँ दवा परिवार
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Tetanus Toxoid

CHEMBL2108875 Phase 4 अनुमोदित Vaccine component
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Tetanus toxoid is a vaccine component prepared by formaldehyde inactivation of tetanus neurotoxin (TeNT) from Clostridium tetani, which when administered as part of immunization schedules (DTaP, Td, Tdap), stimulates production of specific neutralizing antibodies that prevent the neurotoxin from binding to nerve terminals and blocking inhibitory neurotransmitter release. It forms the basis of universal tetanus immunization programs and is included in combination vaccines for pediatric and adult immunization. Booster doses maintain protective antibody levels throughout life.

चिकित्सीय क्षेत्र

HIV/एड्स अग्नाशय कैंसर अस्थमा इंफ्लेमेटरी बाउल डिज़ीज़ एटोपिक डर्मेटाइटिस (एक्जिमा) ओवेरियन कैंसर कोलोरेक्टल कैंसर क्रॉनिक किडनी डिज़ीज़ क्षय रोग (ट्यूबरकुलोसिस) जनरलाइज़्ड एंग्ज़ाइटी डिसऑर्डर टाइप 2 मधुमेह थायरॉइड कैंसर दर्द प्रबंधन दीर्घकालिक दर्द नॉन-स्मॉल सेल लंग कैंसर प्रोस्टेट कैंसर मलेरिया मल्टीपल स्क्लेरोसिस मूत्राशय कैंसर मेलानोमा मोटापा रुमेटॉइड आर्थराइटिस लिम्फोमा ल्यूकेमिया संक्रामक रोग स्तन कैंसर हेपेटाइटिस C

क्रिया का तंत्र

As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Tetanus toxoid is a vaccine component prepared by formaldehyde inactivation of tetanus neurotoxin (TeNT) from Clostridium tetani, which when administered as part of immunization schedules (DTaP, Td, Tdap), stimulates production of specific neutralizing antibodies that prevent the neurotoxin from binding to nerve terminals and blocking inhibitory neurotransmitter release. It forms the basis of universal tetanus immunization programs and is included in combination vaccines for pediatric and adult immunization. Booster doses maintain protective antibody levels throughout life.

As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.

Yes, Tetanus Toxoid is an approved drug. It has reached clinical phase 4. It is classified as a Vaccine component.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108875. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.